immune system
• increased infiltration at sites of infection
|
• increased infiltration at sites of infection
|
• increased infiltration at sites of infection
|
• increased infiltration of myeloid derived dendritic cells at infection sites
|
• inability or reduced ability to produce IFN gamma in response to bacterial infection
(J:91014)
|
• elevated Il4 production
|
• defective response to lipopolysaccharide
(J:70821)
• unable to resolve Leishmania major infections
(J:91014)
• develop nonhealing lesions by 33 days after infection
(J:91014)
• formation of lesions slower after infection
(J:91014)
• develop higher parasite loads at sites of infection
(J:91014)
|
hematopoietic system
• increased infiltration at sites of infection
|
• increased infiltration at sites of infection
|
• increased infiltration at sites of infection
|